Picture [LSA] – The Business Web Portal 650x89px
Document › Details

UGA Biopharma GmbH. (8/22/17). "Press Release: Collaboration between Batavia Biosciences and UGA Biopharma".

Organisations Organisation UGA Biopharma GmbH
  Organisation 2 Batavia Biosciences B.V.
  Group Batavia (Group)
Products Product cell line development (recombinant protein production)
  Product 2 STEP® cell line technology
Index term Index term Batavia–UGA Biopharma: cell line development, –201708 collab devleopm of 2 enzmye expressing monoclonal cell lines for biopharma production
Person Person Däbritz, Frank (UGA Biopharma GmbH 201708 Marketing + Sales)

Both companies have the ambition to provide services and technologies supporting the development of high quality and affordable biopharmaceuticals. Through the partnership, two enzyme expressing monoclonal cell lines are now delivered. They were developed and validated by Batavia Biosciences using STEP® technology, and were guided by UGA Biopharma´s in-depth knowledge and experience in the development of cell lines for biosimilar and NBE drugs.

Dr. Frank Däbritz (Project Manager UGA) adds: “It was a pleasure to collaborate with Batavia Biosciences and to profit from the scientific experience of both companies to realize more successful projects in a short time”.

Record changed: 2017-08-30


Picture [LSA] – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top